Written Question · S4W-13200 · Session 4
Whether it plans to review the NHS's provision of emergency hormonal contraception to assess whether there is a need to include newer and m…
The question
To ask the Scottish Government whether it plans to review the NHS's provision of emergency hormonal contraception to assess whether there is a need to include newer and more effective methods of emergency contraception.
The answer
There are currently two types of emergency hormonal contraception (EHC) licensed for use in Scotland:
Levonorgestrel (known as Levonelle) – which is widely available for use up to 72 hours (3 days) after unprotected sexual intercourse or contraception failure and is available free of charge through community pharmacies, sexual health centres and GPs.
Ulipristal acetate (known as ellaOne) – which is available for use up to 120 hours (5 days) after unprotected sexual intercourse or contraception failure. ellaOne is available only on prescription due to licencing restrictions imposed on all new medicines. ellaOne is available from GPs or sexual health clinics.
In addition, an intrauterine device (IUD) can be used up to 5 days after unprotected sexual intercourse and can then remain in place as longer acting contraception for 5 -10 years. This must be fitted by a trained medical professional.
Any new medicines are carefully reviewed by the EMEA and MHRA before they are licenced for use in the UK. No other EHC is currently licenced for use in the UK at this time, however new products are reviewed when they are made available.
Levonorgestrel (known as Levonelle) – which is widely available for use up to 72 hours (3 days) after unprotected sexual intercourse or contraception failure and is available free of charge through community pharmacies, sexual health centres and GPs.
Ulipristal acetate (known as ellaOne) – which is available for use up to 120 hours (5 days) after unprotected sexual intercourse or contraception failure. ellaOne is available only on prescription due to licencing restrictions imposed on all new medicines. ellaOne is available from GPs or sexual health clinics.
In addition, an intrauterine device (IUD) can be used up to 5 days after unprotected sexual intercourse and can then remain in place as longer acting contraception for 5 -10 years. This must be fitted by a trained medical professional.
Any new medicines are carefully reviewed by the EMEA and MHRA before they are licenced for use in the UK. No other EHC is currently licenced for use in the UK at this time, however new products are reviewed when they are made available.
In the Official Report
No contribution in the Official Report cites S4W-13200 by reference.